Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

4:10 PM ET 10-Q
Financial Results Gladstone Investment Corporation\De GAIN ▶ Call

Gladstone Investment Corporation\De Q2 2026 Results: Net Income $17.1M, Down 40.6% YoY

For the six months ended September 30, 2026, Gladstone Investment Corporation reported total investment income of $52.5 million and net investment income of $20.8 million. Net assets decreased from $668.2 million at the start of the fiscal year to $654.3 million, primarily due to $19.1 million in distributions and $15.6 million in net realized and unrealized losses.

Key figure
Net income $17.1M · -40.6% YoY
4:10 PM ET 8-K
Financial Results Aaon, Inc. AAON

Aaon Financial Results

AAON reported record Q3 2026 net sales of $707.4 million, an 84.1% increase year-over-year, while raising its full-year outlook. Concurrently, the company announced a restatement of its Q1 and Q2 2026 financial statements due to revenue calculation errors and identified a material weakness in internal controls.

Term
Q3 2026

“Our third quarter results reflect strong execution and continued progress turning the investments we have made into stronger operating performance. We delivered record net sales, more than doubled operating income and diluted EPS, improved gross margin 60 basis points sequentially, generated strong cash flow and raised full-year outlook.”

Matt Tobolski, President and CEO of The Aaon Group

“During our third quarter reporting process, we also identified errors in our previously reported first and second quarter financial statements. We corrected those errors and determined that a material weakness existed in our internal control over financial reporting. We take that seriously.”

Matt Tobolski, President and CEO of The Aaon Group
4:10 PM ET 8-K
Financial Results Zentalis Pharmaceuticals, Inc. ZNTL

Zentalis Pharmaceuticals Financial Results

Zentalis Pharmaceuticals reported third quarter 2026 financial results and provided updates on its clinical pipeline, specifically the azenosertib program for ovarian cancer. The company expects a topline readout from the DENALI trial in the first half of 2027 and reported a cash runway extending into the first half of 2028.

“Overall survival data from DENALI Part 1b presented at ESMO reinforce our confidence in azenosertib to offer a differentiated oral treatment for patients with Cyclin E1-positive platinum-resistant ovarian cancer (PROC), if approved.”

Julie Eastland, Chief Executive Officer of Zentalis Pharmaceuticals

“With $228.9 million on the balance sheet providing an anticipated runway into the first half of 2028, we believe we are well resourced to support key DENALI milestones, full enrollment in ASPENOVA and combination trials in ovarian cancer and triple-negative breast cancer.”

Julie Eastland, Chief Executive Officer of Zentalis Pharmaceuticals
4:10 PM ET 8-K
Financial Results Quantum Computing Inc. QUBT

Quantum Computing Financial Results

Quantum Computing Inc. reported Q3 2026 revenue of $9.5 million, a significant increase from $384 thousand in the prior year, driven by recent acquisitions of LSI, NuCrypt, and NHanced. The company reported a net loss of $15.1 million for the quarter while maintaining a strong liquidity position with approximately $1.3 billion in cash and investments.

Term
Q3 2026

“For several years, we've been building the technology and capabilities to make quantum more practical and accessible. We're starting to see those investments come together, and our focus is increasingly shifting from what we can build to what we can put to work for customers. We're encouraged by our progress, but recognize there's considerable work ahead. Our priorities are clear: growing our commercial business, scaling manufacturing and advancing our quantum roadmap. I've always believed that being early creates opportunity. Execution is what makes that opportunity last.”

Dr. Yuping Huang, Chief Executive Officer of QCi
4:10 PM ET 8-K
Financial Results Orasure Technologies Inc OSUR

Orasure Technologies Financial Results

OraSure Technologies reported Q3 2026 financial results with 14% year-over-year revenue growth to $30.9 million, driven by its core business strategy. The company saw GAAP gross margin expansion to 45.2% and received initial orders for its newly launched Colli-Pee Dx and OraQuick Ebola 2.0 products.

Term
Q3 2026

“Our third quarter results demonstrate the continued execution of our strategy. In addition to delivering double-digit year-over-year revenue growth, we meaningfully expanded gross margins and benefited from operational efficiency initiatives that reduced our cost base.”

Carrie Eglinton Manner, President and CEO

“Looking ahead to the fourth quarter and into 2027, we believe we are well positioned for continued revenue growth. Supported by a robust balance sheet, we will continue to invest behind initiatives to accelerate topline growth, improve our operating model, and drive towards profitability.”

Carrie Eglinton Manner, President and CEO
4:10 PM ET 8-K
Financial Results Ameresco, Inc. AMRC

Ameresco Financial Results

Ameresco reported third-quarter 2026 financial results with revenue growth of 10% to $580.3 million and a record total backlog of $7.2 billion. The company saw strong momentum in its Federal and European business lines, including $200 million in new data center energy infrastructure awards.

Term
Q3 2026

“Our third quarter results represented another quarter of strong growth and disciplined execution. We achieved revenue increases across each of our major business lines, expanded margins and continued to build both awarded and contracted backlogs.”

George Sakellaris, CEO

“The strength of our business model is reflected in the diversity of our solutions, markets and customers. We secured over $675 million in additional awards driven by strength in Federal infrastructure and Europe.”

George Sakellaris, CEO
4:10 PM ET 10-Q
Financial Results Brighthouse Life Insurance Co

Brighthouse Life Insurance Q3 2026 Results: Net Income $267M, Down 29.9% YoY

For the nine months ended September 30, 2026, Brighthouse Life Insurance Company reported net income of $445 million, a significant increase from $161 million in the prior year period. However, the company experienced a substantial decrease in total stockholder's equity from $8.08 billion at year-end 2025 to $6.37 billion, primarily driven by $2.16 billion in other comprehensive losses.

Key figure
Net income $267M · -29.9% YoY
4:10 PM ET 10-Q
Financial Results Crescent Capital BDC, Inc. CCAP

Crescent Capital BDC Q3 2026 Results: Net Income $10.1M, Up 42.4% YoY

Crescent Capital BDC, Inc. reported total investment income of $111.1 million for the nine months ended September 30, 2026, a decrease from $126.5 million in the prior year period. Net asset value per share declined to $17.72 from $19.10 at year-end 2025, while net investment income for the first nine months of 2026 was $42.3 million.

Key figure
Net income $10.1M · +42.4% YoY
4:09 PM ET 8-K
Financial Results National Health Investors Inc NHI

National Health Investors Financial Results

National Health Investors reported Q3 2026 financial results, highlighted by a significant increase in net income to $11.47 per diluted share, primarily driven by a $541.6 million gain from the sale of the NHC leased portfolio. The company has closed over $395 million in investments year-to-date and expects to complete additional acquisitions before year-end to drive SHOP segment growth.

Term
Q3 2026

“SHOP and private-pay senior housing remain central to our long-term growth strategy, and we have invested in our executive management team to strengthen operating execution and improve portfolio performance.”

Eric Mendelsohn, NHI’s President and CEO

“We have closed more than $395 million in investments year-to-date and expect to complete significant additional investments before year-end, with ample capital available to fund our current pipeline.”

Eric Mendelsohn, NHI’s President and CEO
4:09 PM ET 10-Q
Financial Results Nerdy Inc. NRDY

Nerdy Q3 2026 Results: Net Loss of $8.59M, Loss Narrows

Nerdy Inc. reported a decrease in revenue to $33.2 million for the third quarter of 2026, down from $37.0 million in the prior year period. Despite the revenue decline, the company narrowed its quarterly net loss to $12.8 million compared to $18.8 million in Q3 2025, driven by significant reductions in sales, marketing, and general administrative expenses.

Key figure
Net loss $8.59M
4:09 PM ET 8-K
Financial Results Lucid Group, Inc. LCID

Lucid Group Financial Results

Lucid Group reported Q3 2026 revenue of $350 million, a 4% year-over-year increase despite a broader market decline. The company reduced quarterly cash consumption by 30% sequentially and secured an additional $1.75 billion in liquidity from the Public Investment Fund (PIF) to fund operations into late 2027.

Term
Q3 2026

“Our transformation is beginning to show progress. We are acting with urgency, strengthening the fundamentals and driving greater discipline, while continuing to invest in the priorities to deliver profitable long-term growth.”

Silvio Napoli, Chief Executive Officer

“The operating reset announced with our Q2 results includes decisive actions to align our manufacturing capacity with demand, reduce inventory and lower operating expenses. These actions are already showing through in Q3, with free cash flow consumption 30% lower sequentially.”

Alexander De Bock, Chief Financial Officer
4:09 PM ET 8-K
Financial Results Ziprecruiter, Inc. ZIP

Ziprecruiter Financial Results

ZipRecruiter reported Q3 2026 financial results with revenue of $124.4 million and net income of $5.1 million, exceeding the high end of its previous guidance. CEO Ian Siegel noted that product improvements and AI-driven marketplace engagement reached all-time highs despite a flat broader hiring environment.

Term
Q3 2026

“ZipRecruiter’s momentum continued to accelerate in the third quarter as we grew revenue and expanded profitability year-over-year. In the third quarter, both revenue and Adjusted EBITDA came in above the high end of our guidance range, and our updated full-year 2026 outlook reflects stronger than expected growth and profitability.”

Ian Siegel, CEO of ZipRecruiter

“As AI reshapes how people look for work, we are betting the platform that wins will be the one that delivers human-to-human connections for both job seekers and employers. That vision defines our roadmap, and we believe we are just getting started.”

Ian Siegel, CEO of ZipRecruiter
4:09 PM ET 8-K
Financial Results Baldwin Insurance Group, Inc. BWIN

Baldwin Insurance Group Financial Results

The Baldwin Insurance Group reported Q3 2026 financial results with total revenue growth of 31% to $480.3 million and Adjusted EBITDA growth of 47% to $106.9 million. The company also provided an update on its pending all-cash take-private merger with Sequence AI Holdings and DFO Management for $32.50 per share, which is expected to close in Q1 2027.

Term
Q3 2026
4:09 PM ET 10-Q
Financial Results SS&C Technologies Holdings Inc SSNC

SS&C Technologies Holdings Q3 2026 Results: Net Income $199M, Down 5.3% YoY

SS&C Technologies reported total revenues of $5,032.8 million for the nine months ended September 30, 2026, representing a 9.0% increase over the prior year. Net income attributable to common stockholders rose to $659.8 million, while the company significantly increased its treasury stock purchases to $760.5 million during the period.

Key figure
Net income $199M · -5.3% YoY
4:09 PM ET 10-Q
Financial Results Annexon, Inc. ANNX

Annexon Q3 2026 Results: Net Loss of $51.2M, Loss Narrows

Annexon, Inc. reported a net loss of $150.7 million for the nine months ended September 30, 2026, compared to $158.4 million in the prior year period. The company strengthened its balance sheet through a $49.3 million term loan and common stock issuances, ending the period with $213.4 million in cash, cash equivalents, and short-term investments.

Key figure
Net loss $51.2M
4:09 PM ET 8-K
Financial Results Qualys, Inc. QLYS

Qualys Financial Results

Qualys reported Q3 2026 revenue of $188.0 million, an 11% increase year-over-year, and GAAP net income of $57.2 million. The company raised its full-year 2026 revenue guidance to a range of $736.9 million to $738.9 million, citing strong adoption of its AI-native Risk Operations Center.

Term
Q3 2026

“In Q3, we delivered another quarter of strong revenue growth and profitability. Increasing adoption of our AI-native Risk Operations Center, driven by our partner-first strategy, reflects accelerating demand for a vendor-neutral platform that actually fixes security issues rather than just reporting them. These results distinguish our competitive position in pre-breach risk management and reinforce our confidence in long-term growth.”

Sumedh Thakar, Qualys president and CEO
4:09 PM ET 8-K
Financial Results PubMatic, Inc. PUBM

PubMatic Financial Results

PubMatic reported record Q3 2026 financial results with revenue growing 17% year-over-year to $79.6 million, driven by strength in CTV and mobile app channels. Alongside the earnings, the Board of Directors authorized a $150 million increase to its share repurchase program and extended the term through December 31, 2028.

Term
through Dec 2028

“We delivered an outstanding third quarter, with revenue growth accelerating for the third consecutive quarter and adjusted EBITDA more than doubling year-over-year. Our investments in advertiser performance are translating into faster, more profitable growth and a more diversified business. At the same time, AI is accelerating the shift from sell-side targeting to sell-side decisioning, enabling buyers to act on richer intelligence closer to the inventory and first party insights. Our proprietary platform intelligence, agentic leadership and AI-native infrastructure position us to lead this shift, deliver more value to buyers and publishers and expand our market opportunity.”

Rajeev Goel, co-founder and CEO of PubMatic

“Our third quarter is the clearest evidence yet that the transformation of our business is working. Revenue and adjusted EBITDA were well ahead of guidance with 17% revenue growth, a 33% adjusted EBITDA margin and strong free cash flow. And this is not a one-quarter event. Nearly two-thirds of our revenue now comes from high-value channels and formats growing more than 50%. For the full year, we expect double-digit revenue growth and adjusted EBITDA margin expansion. Our debt-free balance sheet gives us the flexibility to fund growth and return capital through our expanded repurchase program, as momentum in the business carries into 2027.”

Steve Pantelick, CFO at PubMatic
4:09 PM ET 10-Q
Financial Results MBX Biosciences, Inc. MBX

MBX Biosciences Q3 2026 Results: Net Loss of $62.4M, Loss Widens

MBX Biosciences reported a significant increase in operating expenses for the nine months ended September 30, 2026, with research and development costs rising to $81.5 million. The company's cash and marketable securities position strengthened to approximately $481.6 million following public offerings, while the accumulated deficit grew to $347.5 million. As of November 5, 2026, the company had 49,656,265 shares of common stock outstanding.

Key figure
Net loss $62.4M
4:09 PM ET 10-Q
Financial Results Paradium.AI, Inc. PAAI

Paradium.AI Q3 2026 Results: Net Loss of $3.77M

Paradium.AI, Inc. (formerly The Arena Group Holdings, Inc.) reported a significant revenue decline to $63.1 million for the nine months ended September 30, 2026, compared to $106.6 million in the prior year. The company swung to a net loss of $6.6 million for the period, a sharp contrast to the $119.5 million net income in 2025 which was primarily driven by $96.3 million from discontinued operations.

Key figure
Net loss $3.77M
4:09 PM ET 8-K
Financial Results Onto Innovation Inc. ONTO

Onto Innovation Financial Results

Onto Innovation reported record Q3 2026 revenue of $410 million, an 88% increase year-over-year, driven by strong demand for AI and high-performance computing process control systems. The company achieved a non-GAAP operating margin of 32.6% and ended the quarter with a record backlog exceeding $1.3 billion. Management expects full-year 2026 revenue growth to exceed 45% year-over-year.

Term
Q3 2026

“Our outstanding results this quarter reflect excellent execution by our team and continued strength in the markets we serve. Demand remains robust as increasingly complex device architectures for next-generation AI and high-performance computing drive greater process control requirements.”

Mike Plisinski, chief executive officer of Onto Innovation

“The momentum across our business, combined with the strength of our backlog, which increased in the quarter to more than $1.3 billion, and visibility into our customer investment plans extending out multiple years, gives us increased confidence in the durability of these demand trends.”

Mike Plisinski, chief executive officer of Onto Innovation
4:09 PM ET 10-Q
Financial Results iHeartMedia, Inc. IHRT

iHeartMedia Q3 2026 Results: Net Loss of $8.8M, Loss Narrows

For the nine months ended September 30, 2026, iHeartMedia reported revenue of $2.89 billion, a 5.6% increase over the prior year. Despite this growth, the company recorded a net loss attributable to the company of $186.4 million, though this was a significant improvement from the $431.0 million loss in the same period of 2025.

Key figure
Net loss $8.8M
4:09 PM ET 8-K
Financial Results Kemper Corp KMPR

Kemper Financial Results

Kemper Corporation reported Q3 2026 net income of $52.4 million, a significant improvement from a net loss of $21.0 million in the prior year quarter. The results were driven by improved profitability in the Personal Auto segment, particularly in California, following rate and non-rate actions. Total revenues decreased by $149.1 million to $1,090.6 million, primarily due to lower Specialty Personal Automobile volumes.

Term
Q3 2026

“Our third-quarter results demonstrate continued progress as the actions we’ve taken to improve profitability are taking hold. While there is more work ahead, we are moving in the right direction and remain focused on restoring profitability and building capabilities to position Kemper for durable, profitable growth.”

Stephen J. McAnena, President and Chief Executive Officer
4:08 PM ET 8-K
Financial Results Zymeworks Inc. ZYME

Zymeworks Financial Results

Zymeworks reported Q3 2026 financial results and significantly raised its full-year 2026 revenue guidance to $337M-$351M. The company highlighted the recent FDA approval of Ziihera for first-line GEA, which triggered a $250 million milestone payment from Jazz Pharmaceuticals, and the completion of its acquisition of Theravance Biopharma.

Term
Q3 2026

“We are entering the next phase of Zymeworks growth with a fundamentally stronger and more diversified business. The transformation of Zymeworks is becoming increasingly visible in our financial profile and in the breadth of opportunities available to us.”

Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks

“These advancements demonstrate the strategy we set out a year ago - to build a durable financial foundation through partnered and commercial assets, while maintaining the ability to create additional value through R&D, acquisitions, partnerships and disciplined capital allocation.”

Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks
4:08 PM ET 8-K
Financial Results Trump Media & Technology Group Corp. DJT

Trump Media & Technology Group Financial Results

Trump Media & Technology Group reported Q3 2026 revenue of $3.0 million, a 205% increase year-over-year driven by its new data licensing product and Truth+ subscriptions. The company ended the quarter with a strong balance sheet featuring $2.5 billion in total assets and is progressing toward a merger with TAE Technologies following the SEC declaring its S-4 registration statement effective.

Term
Q3 2026

“We’ve remained committed to capitalizing on our business fundamentals, and that focus is paying off. Revenue grew 205% year-over-year on recurring subscription revenue, our cost structure is inherently leaner, and our balance sheet gives us real flexibility. With our S-4 effective and our special meeting set for December 14th, we are advancing an exciting new chapter for our shareholders. Our commitment to building independent, uncancellable media technology remains unwavering, while TAE’s groundbreaking innovations represent an extraordinary opportunity to advance American energy independen”

Kevin McGurn, Interim CEO of TMTG
4:08 PM ET 10-Q
Financial Results KKR & Co. Inc. KKR

KKR & Co Q3 2026 Results: Net Income $1.16B, Up 29.0% YoY

KKR & Co. Inc. filed its Form 10-Q for the quarter ended September 30, 2026, reporting 892,139,534 shares of common stock outstanding as of November 6, 2026. The filing highlights the company's ongoing structural reorganization, including the planned 'Sunset Date' by December 31, 2026, which will eliminate voting control by the Series I preferred stockholder and establish one-vote-per-share rights for common stock.

Key figure
Net income $1.16B · +29.0% YoY
4:08 PM ET 8-K
Financial Results CervoMed Inc. CRVO

CervoMed Financial Results

CervoMed reported Q3 2026 financial results and provided updates on its neflamapimod clinical program, including the removal of FDA drug exposure limits and the receipt of an Innovation Passport designation in the UK for dementia with Lewy bodies. The company ended the quarter with $31.1 million in cash and cash equivalents, which is expected to fund operations into late 2025.

Term
Q3 2026

“The Company believes that the neflamapimod clinical development program has been significantly de-risked through the presentation and publication of compelling, supportive datasets throughout this year and the ability to advance the 100mg BID dosing regimen, strengthening its position as a potential therapeutic for dementia with Lewy bodies and other devastating neurodegenerative disorders.”

John Alam, MD, Chief Executive Officer of CervoMed

“As we look ahead to the remainder of the year and into 2027, we believe neflamapimod is well-positioned to succeed in the clinic, drive stockholder value, and ultimately, if approved, bring a transformative therapy to a market with massive, unmet medical needs.”

John Alam, MD, Chief Executive Officer of CervoMed
4:08 PM ET 10-Q
Financial Results Powerfleet, Inc. AIOT

Powerfleet Q2 2026 Results: Net Loss of $6.85M, Loss Widens

Powerfleet, Inc. reported total revenues of $115.7 million for the quarter ended September 30, 2026, a slight increase from $111.7 million in the prior year. The company experienced a net loss attributable to common stockholders of $6.85 million ($0.05 per share) for the quarter, compared to a net loss of $4.29 million ($0.03 per share) in the same period of 2025.

Key figure
Net loss $6.85M
4:08 PM ET 10-Q
Financial Results Trump Media & Technology Group Corp. DJT

Trump Media & Technology Group Q3 2026 Results: Turns Profitable, Net Income $410M

For the quarter ended September 30, 2026, Trump Media & Technology Group Corp. reported a significant net income of $409.7 million, primarily driven by a $378.1 million gain on digital assets. This represents a substantial turnaround from the $54.8 million net loss in the prior year's quarter, despite total assets decreasing to $2.48 billion from $2.63 billion at year-end 2025.

Key figure
Net income $410M
4:08 PM ET 10-Q
Financial Results Thryv Holdings, Inc. THRY

Thryv Holdings Q3 2026 Results: Net Loss of $103M

Thryv Holdings reported a significant operating loss of $110.3 million for the third quarter of 2026, driven primarily by a $94.8 million impairment charge. Total revenue declined to $118.9 million from $137.4 million in the prior year period, while the company disclosed substantial doubt about its ability to continue as a going concern.

Key figure
Net loss $103M
4:08 PM ET 10-Q
Financial Results Whitehawk Therapeutics, Inc. WHWK

Whitehawk Therapeutics Q3 2026 Results: Net Loss of $21.2M, Loss Widens

Whitehawk Therapeutics reported a net loss of $60.0 million for the nine months ended September 30, 2026, compared to a net income of $2.7 million in the prior year period, which had been bolstered by an $87.3 million gain on the sale of a business. The company ended the quarter with $169.7 million in cash, cash equivalents, and short-term investments following a private placement that raised approximately $81.7 million in net proceeds.

Key figure
Net loss $21.2M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.